Expertise in
2
conditions

Thierry Prazuck

Orleans, FR 
Expertise in
2
conditions
Orleans, FR 

Overview

Thierry Prazuck practices practicing medicine in Orleans, France.

Mr. Prazuck is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Severe Acute Respiratory Syndrome (SARS), HIV/AIDS, Pneumonia, and COVID-19.

He is actively involved in clinical research, co-authoring 81 peer reviewed articles and participating in 6 clinical trials.

Gender

Male

Locations

Orleans, France
Other Locations
France
Chateauroux, France
Amiens, France
Saint-andre-de-sangonis, France
Tours, France
Paris, 75013, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Study Among People Living With HIV and Their Health Professionals of Associated Factors of Resilience to Self-stigma
Study Among People Living With HIV and Their Health Professionals of Associated Factors of Resilience to Self-stigma
Enrollment Status: Completed
Publish Date: August 07, 2026
Study of the Kinetics of COVID-19 Antibodies for 24 Months in Patients With Confirmed SARS-CoV-2 Infection According to the Clinical Severity of the Infection.
Study of the Kinetics of COVID-19 Antibodies for 24 Months in Patients With Confirmed SARS-CoV-2 Infection According to the Clinical Severity of the Infection.
Enrollment Status: Completed
Publish Date: December 30, 2025
Intervention Type: Other
Study Phase: Not Applicable
Randomized Clinical Trial to Evaluate the Interest of a Down-scaled Treatment Strategy Using Dual Therapy (Nucleoside Analogs) in HIV Infected Patients Already Being Treated Using Triple Therapy, Who Present With a Successful Virological Control and for Which the HIV Reservoir is Low to Moderate
Randomized Clinical Trial to Evaluate the Interest of a Down-scaled Treatment Strategy Using Dual Therapy (Nucleoside Analogs) in HIV Infected Patients Already Being Treated Using Triple Therapy, Who Present With a Successful Virological Control and for Which the HIV Reservoir is Low to Moderate
Enrollment Status: Completed
Publish Date: December 26, 2025
Intervention Type: Drug
Study Phase: Phase 3
Effects of Cannabidiol (CBD) on the Activation of Autophagy and Inflammation Genes, Functional Consequences in Virologically Controlled HIV-infected Patients
Effects of Cannabidiol (CBD) on the Activation of Autophagy and Inflammation Genes, Functional Consequences in Virologically Controlled HIV-infected Patients
Enrollment Status: Completed
Publish Date: April 03, 2023
Intervention Type: Drug
Study Phase: Phase 2
Effect of Tenofovir/Emtricitabine Short Course on Viral Clearance in Patients Recently Infected With SARS-COV2 (Covid-19) Not Requiring Hospitalization: a Phase IIB/III Multicenter Open-label Randomized Controlled Trial
Effect of Tenofovir/Emtricitabine Short Course on Viral Clearance in Patients Recently Infected With SARS-COV2 (Covid-19) Not Requiring Hospitalization: a Phase IIB/III Multicenter Open-label Randomized Controlled Trial
Enrollment Status: Completed
Publish Date: July 01, 2021
Intervention Type: Drug
Study Drugs: Tenofovir, Emtricitabine
Study Phase: Phase 2/Phase 3
Diagnostic Performance Evaluation of a Novel SARS-CoV-2 (COVID-19) Antigen Detection Test on Nasopharyngeal Specimens i
Diagnostic Performance Evaluation of a Novel SARS-CoV-2 (COVID-19) Antigen Detection Test on Nasopharyngeal Specimens i
Enrollment Status: Completed
Publish Date: December 07, 2020
Intervention Type: Diagnostic test
Study Phase: Not Applicable
View 5 Less Clinical Trials

81 Total Publications

Complement augments antibody neutralization of SARS-CoV-2 variants.
Complement augments antibody neutralization of SARS-CoV-2 variants.
Journal: Science translational medicine
Published: July 22, 2026

Frequently Asked Questions about Thierry Prazuck

Is Thierry Prazuck a top-rated expert for Severe Acute Respiratory Syndrome (SARS)?

MediFind is an objective health platform that identifies experts based on real-world data. Thierry Prazuck is classified as an Advanced expert for Severe Acute Respiratory Syndrome (SARS), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Thierry Prazuck participate in research or clinical trials?

Yes. Thierry Prazuck has published 81 articles and abstracts on conditions like Severe Acute Respiratory Syndrome (SARS). You can view a list of Thierry Prazuck's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Prazuck's expertise for a condition
ConditionClose
      View All 12 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile